Evaluation of an autologous cancer vaccine for the treatment of metastatic canine hemangiosarcoma: a preliminary study

BACKGROUND: Canine hemangiosarcoma (HSA) is an aggressive cancer arising from multipotential bone marrow-derived stem cells. Anthracycline chemotherapy drugs have been the mainstay adjuvant chemotherapy following surgery with only modest improvement in survival and an attendant risk for adverse even...

Descripción completa

Detalles Bibliográficos
Autores principales: Lucroy, Michael D., Clauson, Ryan M., Suckow, Mark A., El-Tayyeb, Ferris, Kalinauskas, Ashley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672887/
https://www.ncbi.nlm.nih.gov/pubmed/33208160
http://dx.doi.org/10.1186/s12917-020-02675-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672887/
https://www.ncbi.nlm.nih.gov/pubmed/33208160
http://dx.doi.org/10.1186/s12917-020-02675-y

Ejemplares similares